Question 13 of 24
Vaccines & recommended check-ups?
The short answer
US Preventive Services Task Force recommendations for breast, colorectal, cervical and prostate cancer screening rest on systematic reviews of randomised trial evidence plus decision modelling. They specify who should be screened and how often — but the underlying trials mostly measure disease-specific rather than all-cause mortality, and the age ranges and intervals are revised periodically and genuinely debated.
Pick one to continue — the dead don't get to skip homework.
The most boring miracle of all time
💀 A grim little fact
Vaccines don't get parades, but they should. A landmark Lancet/WHO analysis estimated that global immunization saved at least 154 million lives over 50 years — that's about 6 lives every single minute, for half a century. The measles vaccine alone accounts for roughly 94 million of them.
Check-ups are the sequel nobody watches: catching a problem while it's still a whisper is dramatically cheaper — and less fatal — than meeting it once it's shouting.
Vaccines: ~154 million lives saved in 50 years (~6 per minute).
🔮 Myth vs. Morty
Myth: "I'm young and healthy, check-ups are for hypochondriacs." The whole point of screening is that the scariest stuff — high blood pressure, early cancers, rising cholesterol — is silent. Feeling fine is not the same as being fine; it's just the part of the movie before the music changes.
Sources: WHO / The Lancet immunization impact study (2024) · Entertainment only — not medical advice.
Vaccines, screening and life expectancy: what the evidence shows
Last reviewed · compiled by the ExpireOnDate editorial team · not medically reviewed
What the research shows
The USPSTF recommendation calls for biennial screening mammography in average-risk women aged 40 to 74.
average-risk women · United States · clinical practice guideline based on systematic evidence review · 2024 · US Preventive Services Task Force
A USPSTF-commissioned decision-analytic modelling study updated the estimated benefits and harms of different mammography strategies to inform that recommendation.
average-risk US women · United States · decision-analytic modelling study · 2024 · USPSTF / NCBI Bookshelf
What it does not show
Most screening trials are powered to detect a fall in deaths from that specific cancer, and few have shown a statistically significant fall in all-cause mortality — so the population-wide survival benefit is smaller and harder to demonstrate than cancer-specific headlines suggest. Screening also carries overdiagnosis, finding cancers that would never have caused harm, and lead-time bias, where survival looks longer simply because diagnosis came earlier without the date of death moving.
Every figure on this page describes a population, not a person. Associations measured across thousands of people cannot tell any individual how long they will live, and nothing here is medical advice. If something on this page concerns you, talk to a doctor rather than a comedy website.
References
- Recommendation: Breast Cancer: Screening. US Preventive Services Task Force (2024). primary source; accessed 2026-08-15.
- Breast Cancer Screening With Mammography: An Updated Decision Analysis for the U.S. Preventive Services Task Force. USPSTF / NCBI Bookshelf (2024). primary source; accessed 2026-08-15.
Spotted an error or a better source? Tell us — corrections are logged and the review date updated.